In this winter, the market of respiratory chemicals reached 50 billion yuan, and the share of antiallergic drugs soared

Since the winter of 2017, the North has been dry with little snow and the South has been cold and humid, which has led to an increase in the number of people with allergic reactions, and the number of people with cold (especially influenza) has also increased significantly, so the market of anti allergic drugs has grown rapidly According to the data of minenet, the total sales volume of respiratory chemicals in 2016 was RMB 50 billion, of which the market of respiratory chemicals in public hospitals in key cities reached RMB 4.66 billion, an increase of 13.66% over the previous year Figure 1: respiratory chemicals market of public hospitals in key cities (unit: 100 million yuan) none = "shifumousedownstyle ('shifu bus')" style = "margin: 1em Auto; padding: 0px; max width: 100%; color: rgb (62, 62, 62); font family:" hiragino sans GB "," Microsoft YaHei ", Arial, sans serif; font size: 16px; line-height: 25.6px; widows: 1; border-style: none none solid; text-align: center; border-bottom-width: 1px; border-bottom-color: rgb(0, 0, 0); box-sizing: border-box !im portant; word-wrap: break-word !im portant; "The incidence rate of allergy increased, and the market for anti allergic drugs increased According to WHO data, 20% to 30% of the world's population was troubled by allergy symptoms, showing a trend of increasing year by year with the development of modern society For moderate to severe allergic diseases, drugs are the only treatment According to foreign data, the market scale of antiallergic drugs in the global top 500 best-selling drugs in 2016 was US $5.215 billion, down 1.79% year on year, mainly due to the expiration of original research patent and the lack of new oral antiallergic drugs Systemic antihistamines account for 46% of the total market Figure 2: global best-selling anti allergy drug market (unit: US $100 million) Figure 3: global systemic anti histamine drug market (unit: US $100 million) in China, the incidence of allergies is similar to that of foreign countries, with 270 million people affected by different degrees of allergies In particular, people living in coastal or alpine areas have hundreds of millions of people suffering from allergic rhinitis or allergic asthma, and the incidence rate of this disease is increasing rapidly In recent years, with the deterioration of China's atmospheric environment, the increase of chemical daily necessities and the interference of spring pollen, skin redness, pruritus, macula and respiratory system abnormalities and other common allergic inflammatory diseases occur frequently Although most people don't pay enough attention to mild allergy, with the improvement of civilization, the disease has gradually been paid attention to, which leads to the growth of anti allergy drug market   none="shifuMouseDownStyle('shifu_bus_002')" style="margin: 1em auto; padding: 0px; max-width: 100%; color: rgb(62, 62, 62); font-family: "Hiragino Sans GB", "Microsoft YaHei", Arial, sans-serif; font-size: 16px; line-height: 25.6px; widows: 1; border-style: none none solid; text-align: center; border-bottom-width: 1px; Border-bottom-color: RGB (0, 0, 0); box-sizing: border-box! Im portant; word-wrap: break-word! Im portant; "> antihistamine market scale has expanded year by year, the incidence rate of allergic diseases in China has been increasing In recent years, the domestic and foreign pharmaceutical products and examination and treatment methods are also gradually integrated, all of which have promoted the growth of the Chinese antihistamine market According to the data of mienei.com, in 2016, the sales volume of systemic antiallergic drugs (mainly antihistamines) in China exceeded 5 billion yuan, an increase of 5.1% over the previous year Among them, the amount of antihistamines used in public hospitals in key cities reached 476 million yuan, an increase of 13.72% over the previous year Figure 4: antihistamines market of public hospitals in key cities in China (unit: 100 million yuan) From the perspective of three major end markets and six major markets, public hospitals in cities in China are still the main consumers of antihistamines, accounting for about half of the total consumption With the separation of national medical system, the diversion of patients from tertiary hospitals to primary hospitals, and the improvement of national self-health consumption level, the consumption proportion of antihistamines retail pharmacies has increased year by year, and the primary market can not be underestimated This trend will be more obvious in 2017   none="shifuMouseDownStyle('shifu_bus_002')" style="margin: 1em auto; padding: 0px; max-width: 100%; color: rgb(62, 62, 62); font-family: "Hiragino Sans GB", "Microsoft YaHei", Arial, sans-serif; font-size: 16px; line-height: 25.6px; widows: 1; border-style: none none solid; text-align: center; border-bottom-width: 1px; Border bottom color: rgb (0, 0, 0); box sizing: border box! Im portant; word wrap: break word! Im portant; "> the structure of antihistamines is gradually improved Antihistamines are widely used in clinical, mainly used for desensitization of a variety of allergic diseases It also plays an important role in the treatment of urticaria, allergic rhinitis and allergic asthma, and can reduce a variety of allergic reaction symptoms With the integration of domestic and foreign drug markets, the product structure of domestic antihistamines is gradually improved, mainly including piperidine, monoethanolamine, alkylamine, phenothiazine, piperazine and other categories The upgrading of products has been accelerated from the first generation of antihistamines to the third generation of new antihistamines All of these have accelerated the adjustment and upgrading of antihistamines product structure   In the latest 2017 medical insurance catalogue, there are 19 kinds of antihistamines for general use, including 6 class a drugs, which are diphenhydramine, chlorphenamine, cyproheptadine, promethazine, promethazine for children and loratadine, and the rest are class B drugs, including levocetirizine, desloratadine, olotadine, betastatin, ebastine, emestine, and imipenem Zoistine, etc The newly added varieties of 2017 medical insurance catalogue are emestine, betastatin, orotadine and desloratadine The oral regular release of loratadine is adjusted from the original class B drug to the class a drug, which fully reflects the high attention of the national anti allergy clinical drug   none="shifuMouseDownStyle('shifu_bus_002')" style="margin: 1em auto; padding: 0px; max-width: 100%; color: rgb(62, 62, 62); font-family: "Hiragino Sans GB", "Microsoft YaHei", Arial, sans-serif; font-size: 16px; line-height: 25.6px; widows: 1; border-style: none none solid; text-align: center; border-bottom-width: 1px; border-bottom-color: rgb(0, 0, 0); box-sizing: border-box !im portant; word-wrap: break-word !im portant; "> in 2016, the top 10 antihistamines were competing In 2016, the top 10 antihistamines in public hospitals in key cities were medloratadine, loratadine, ebastine, levocetirizine, cetirizine, desloratadine, fexofenadine, mizolastine, epistatin and lupatadine The growth rate of these drugs was 12.47% year on year, accounting for 93.21% of 30 statistical drugs, thus forming a high market concentration Figure 5: Top 5 market of antihistamines in public hospitals of key cities (unit: 10000 yuan) none = "shifumousedown ('shifu_t_002 ')" style = "margin: 1em Auto; padding: 0.5em 0px; max width: 100%; color: rgb (62, 62, 62); font family:" hiragino Sans GB "," Microsoft YaHei ", Arial, sans serif; font size: 16px; line height: 25.6px; width: 1; border: none; Text align: Center; width: 670px; box sizing: border box! Im portant; word wrap: break word! Im portant; "> epilogue allergy is a complex disease, which can be divided into material allergy and physical allergy It is also the main cause of respiratory diseases, such as acute and chronic rhinitis, cough and asthmatic symptoms, which are mostly related to physical allergy Allergy is a disease that can't be underestimated, but it's not taken seriously With the deepening of the reform of the national medical system, antihistamines in three major end markets and six major markets in China, urban public hospitals and county-level public hospitals will be in a steady and declining trend, while antihistamines in urban community centers, township hospitals and physical pharmacies will show a trend of increasing year by year, which is consistent with the gradual implementation of the policies issued by the state.